Why is Bandaram Pharma falling/rising?

As of 04-Jul, Bandaram Pharma Packtech Ltd is experiencing a price increase, currently at 41.50, reflecting a change of 0.68 or 1.67% upward. The stock has shown strong performance recently, outperforming its sector by 1.71% today and achieving a consecutive gain over the last three days with an impressive return of 8.44% during this period. Additionally, the stock's one-year return stands at 29.85%, significantly higher than the market's return of 2.13%. However, despite these positive indicators, the company has a weak long-term fundamental strength, evidenced by a high Debt to EBITDA ratio of 6.31 times and a low average Return on Capital Employed (ROCE) of 5.74%, which may raise concerns among investors.
Broader Market Context: In the short term, Bandaram Pharma's performance has been notably better than the benchmark, with a 1-week return of +3.47% compared to the Sensex's -0.74%. This indicates that the stock is gaining traction in a challenging market environment. The rising investor participation, as indicated by a significant increase in delivery volume, further supports the stock's upward movement. However, the company's flat results in recent quarters, including a substantial decline in net sales, may pose risks for future performance, suggesting that while the stock is currently rising, underlying fundamentals could impact its sustainability in the long run.